We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current XRTX market cap is 3.31M. The company's latest EPS is USD -0.6199 and P/E is -2.08.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.16M | -1.8M | -1.09M | -1.49M | -875k |
| Net Income | -1.33M | 2.7M | -3.14M | 290k | -587k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -368k | -1.14M | -2.91M | -10.29M | -6.05M |
| Net Income | -629k | -1.28M | -1.58M | -7.72M | -2.16M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.64M | 5.47M | 6.05M | 4.8M | 3.85M |
| Total Liabilities | 554k | 826k | 3.56M | 2.09M | 1.72M |
| Total Equity | 6.09M | 4.64M | 2.49M | 2.71M | 2.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.09M | 2.29M | 17.38M | 12.37M | 5.47M |
| Total Liabilities | 1.3M | 1.03M | 4.18M | 5.38M | 826k |
| Total Equity | -211k | 1.26M | 13.2M | 7M | 4.64M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.29M | -6.58M | -1.3M | -2.04M | -2.79M |
| Investing | -36k | -46k | -3k | -12k | -35k |
| Financing | -49k | -361k | 1.7M | 1.7M | 1.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -249k | -728k | -4.8M | -8.96M | -6.58M |
| Investing | -7k | -14k | -32k | -46k | -46k |
| Financing | 55k | 855k | 19.37M | 4.71M | -361k |
| Market Cap | 3.31M |
| Price to Earnings Ratio | -2.08 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.3 |
| Price to Book Ratio | 0.97 |
| Dividend Yield | - |
| Shares Outstanding | 3.48M |
| Average Volume (1 week) | 30.04k |
| Average Volume (1 Month) | 96.05k |
| 52 Week Change | -58.52% |
| 52 Week High | 7.00 |
| 52 Week Low | 0.85 |
| Spread (Intraday) | 0.09 (9.31%) |
| Company Name | XORTX Therapeutics Inc |
| Address |
550 burrard street, suite 2900 vancouver, british columbia V6C OA3 |
| Website | https://www.xortx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
